12/4/2008

European regulators have approved St. Jude Medical's AnalyST implantable cardioverter defibrillator. The device is designed to continuously monitor certain changes in the heart's electrical system, helping doctors to keep track of disease progression. The company also is seeking FDA approval for the product.

Related Summaries